Indraprastha Medical Corporation, a company in the Hospital industry, reported revenue of ₹413 crore and net profit of ₹54 crore for the September 2026 quarter.
Indraprastha Medical Corporation (NSE: INDRAMEDCO) closed at ₹362.60 on 20 Nov 2026, down 31.7% over the past year. Its market capitalisation is ₹3,324 crore and it trades at 17.3 times earnings.
Incorporated in 1988 as a JV between Apollo Hospitals Enterprise Ltd. (AHEL) and the Delhi Government, Indraprastha Medical Corporation Ltd. is a super speciality tertiary care hospital in New Delhi. The Co. currently has 52 speciality departments.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.